Featured content
What will shape the future of advanced therapies in Europe?
Following his opening keynote at this year’s Advanced Therapies Europe conference in Barcelona, Professor Jacob George, MHRA Chief Medical & Scientific Officer, explores the evolving regulatory landscape for advanced therapy medicinal products.
ArticleStrategies for scaling complex next-generation biologics
As biologic drug formats grow more sophisticated, scalable success depends on embedding manufacturability, analytics and quality thinking into molecular design from the very beginning of development.
ReportCPHI Milan 2026 preview: key themes and emerging trends
Explore the key themes, technologies and emerging trends shaping pharmaceutical development, manufacturing and commercialisation ahead of CPHI Milan 2026.
OpinionHow can we ensure consistency in decentralised cell therapy manufacturing?
Following her presentation at Advanced Therapies Europe, Charlotte Serra navigates the complexities of decentralised cell therapy manufacturing.
News
NewsNovo secures €1.17bn long-acting injectable deal with Nanexa
Licensing agreement focuses on a delivery technology that provides sustained-release injectable peptides and offers potential to reduce treatment burden in obesity and type 2 diabetes.
NewsMHRA approves new combination therapy for small cell lung cancer
Authorisation is based on data showing lurbinectedin plus atezolizumab facilitated a meaningful improvement in survival and progression-free outcomes compared with atezolizumab alone in ES-SCLC.
NewsAmgen reports positive topline Phase 3 Sjögren’s results
Dazodalibep met the primary endpoint in a Phase 3 study, demonstrating a statistically significant improvement in systemic disease activity in people with moderate-to-severe systemic Sjögren’s disease.
NewsEur. Ph. revises monographs to aid detection of adulterated excipients
The new gas chromatography test strengthens quality control within the pharmaceutical supply chain as well as availability of safe, high-quality medicines, particularly for children.
From our partners
European Pharmaceutical Review Issue 2 2026
EPR Issue 2 includes articles on manufacturing, drug formulation, microbiology, downstream bioprocessing, and more.
Demonstrating airflow integrity and VHP compatibility in automated settle plate monitoring
Download this application note to learn how the MAS-100 Libra® supports automated settle plate exposure while maintaining airflow integrity, first-air conditions and effective VHP decontamination in critical aseptic environments.
European Pharmaceutical Review Issue 2 (2026): Micro/RMM In-Depth Focus
As pharmaceutical microbiology evolves, manufacturers are balancing contamination control, regulatory expectations and the need for faster, more actionable data. This In-Depth Focus explores emerging approaches across microbiological testing, monitoring and rapid methods.
Opinion and interviews
What will shape the future of advanced therapies in Europe?
Following his opening keynote at this year’s Advanced Therapies Europe conference in Barcelona, Professor Jacob George, MHRA Chief Medical & Scientific Officer, explores the evolving regulatory landscape for advanced therapy medicinal products.
How can we ensure consistency in decentralised cell therapy manufacturing?
Following her presentation at Advanced Therapies Europe, Charlotte Serra navigates the complexities of decentralised cell therapy manufacturing.
- Previous
- Next
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
Upcoming Webinars
Webinar
Ensuring drug quality: mastering stability testing in pharma
Join this webinar to discover how UV-Vis spectroscopy and gas chromatography support API monitoring, testing and analysis.
Webinar
Modernising pharma QA/QC laboratories: preparing for a more connected, compliant future
Join this webinar to discover how modern QA/QC laboratories are embracing digital transformation to enhance compliance, workflows and data integrity to build a more connected, future-ready pharmaceutical quality ecosystem.
Webinar
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
In this webinar, Particle Measuring Systems will share a case study of a biopharmaceutical company developing and applying a structured global rationale for the implementation of continuous viable environmental monitoring with a single-use microbial impactor within aseptic manufacturing environments.
Webinar
The impact of negative control stability on recombinant endotoxin testing
In this webinar, FUJIFILM Wako Chemicals Europe GmbH will present the results of a study evaluating how NC stability in endotoxin detection reagents affects assay performance.
Webinar
Building quality and consistency into accelerated cell and gene therapy development
How can cell and gene therapy manufacturers move programmes forward faster without compromising quality, scalability or regulatory readiness?
Ensuring drug quality: mastering stability testing in pharma
Modernising pharma QA/QC laboratories: preparing for a more connected, compliant future
From passive to active air monitoring in aseptic filling: a risk-based approach to replacing settle plates
The impact of negative control stability on recombinant endotoxin testing
Building quality and consistency into accelerated cell and gene therapy development
On-demand Webinars
- Previous
- Next
